| Net income | 264.71M |
| Depreciation and amortization of property | |
| Amortization of deferred expenses, share-based incentive compensation and interest rate hedge | |
| Amortization of intangible assets related to acquisitions | |
| Loss on extinguishment of debt | 0 |
| Deposits with banks | |
| Cash deposited with clearing organizations and other segregated cash | |
| Receivables-net | -43.59M |
| Investments | 79.7M |
| Other assets | -61.78M |
| Deposits and other payables | 70.17M |
| Accrued compensation and benefits and other liabilities | |
| Net cash provided by (used in) operating activities | |
| Distributions relating to equity method investments | |
| Additions to property | -22.07M |
| Disposals of property | 866K |
| Proceeds from sales and maturities of available-for-sale securities | |
| Net cash provided by (used in) investing activities | |
| Contribution from noncontrolling interests | 93K |
| Excess tax benefits from share-based incentive compensation | 2.34M |
| Other financing activities | 30.52M |
| Senior borrowings | 0 |
| Capital lease obligations | -1.23M |
| Distributions to noncontrolling interests | |
| Repurchase of common membership interests from members of LAZ-MD Holdings | |
| Purchase of Class A common stock | -228.87M |
| Class A common stock dividends | -289.33M |
| Settlement of vested share-based incentive compensation | -55.56M |
| Other financing activities | -3.08M |
| Net cash used in financing activities | |
| EFFECT OF EXCHANGE RATE CHANGES ON CASH | 48K |
| NET DECREASE IN CASH AND CASH EQUIVALENTS | -278.2M |
| CASH AND CASH EQUIVALENTS-January 1 | 1.13B |
| CASH AND CASH EQUIVALENTS-June 30 | 853.89M |